At close: September 26 at 4:00 PM EDT
Research Analysis
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 7 | 7 | 8 | 8 |
| Avg. Estimate | 2.13 | 2.34 | 9.16 | 10.07 |
| Low Estimate | 2.1 | 2.26 | 9.12 | 9.83 |
| High Estimate | 2.18 | 2.38 | 9.2 | 10.2 |
| Year Ago EPS | 2.03 | 2.22 | 8.83 | 9.16 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 9 | 9 |
| Avg. Estimate | 1.33B | 1.38B | 5.5B | 5.84B |
| Low Estimate | 1.32B | 1.37B | 5.48B | 5.8B |
| High Estimate | 1.36B | 1.39B | 5.53B | 5.92B |
| Year Ago Sales | -- | -- | 5.14B | 5.5B |
| Sales Growth (year/est) | -- | -- | 7.00% | 6.30% |
Earnings History
| CURRENCY IN USD | 9/30/2023 | 12/31/2023 | 3/31/2024 | 6/30/2024 |
|---|---|---|---|---|
| EPS Est. | 2 | 2.17 | 2.35 | 1.98 |
| EPS Actual | 2.03 | 2.22 | 2.58 | 2.03 |
| Difference | 0.03 | 0.05 | 0.23 | 0.05 |
| Surprise % | 1.50% | 2.30% | 9.80% | 2.50% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 2.13 | 2.34 | 9.16 | 10.07 |
| 7 Days Ago | 2.13 | 2.34 | 9.16 | 10.07 |
| 30 Days Ago | 2.13 | 2.34 | 9.16 | 10.07 |
| 60 Days Ago | 2.17 | 2.36 | 9.14 | 10.04 |
| 90 Days Ago | 2.19 | 2.37 | 9.19 | 10.08 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Sep 2024) | Next Qtr. (Dec 2024) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | 1 |
| Up Last 30 Days | -- | -- | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | STE | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 4.90% | -- | -- | 5.60% |
| Next Qtr. | 5.40% | -- | -- | 9.90% |
| Current Year | 3.70% | -- | -- | 3.40% |
| Next Year | 9.90% | -- | -- | 12.70% |
| Next 5 Years (per annum) | 10.00% | -- | -- | 11.90% |
| Past 5 Years (per annum) | 12.46% | -- | -- | -- |
Upgrades & Downgrades
| Reiterates | Needham: Hold | 8/8/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 8/7/2024 |
| Reiterates | Stephens & Co.: Overweight to Overweight | 8/7/2024 |
| Reiterates | JMP Securities: Market Outperform to Market Outperform | 7/26/2024 |
| Reiterates | Piper Sandler: Neutral to Neutral | 5/10/2024 |
| Reiterates | Needham: Hold | 5/10/2024 |
Related Tickers
IART Integra LifeSciences Holdings Corporation
17.47
+1.93%
PEN Penumbra, Inc.
191.63
+2.54%
QDEL QuidelOrtho Corporation
44.18
+1.89%
BRKR Bruker Corporation
70.44
+4.74%
INSP Inspire Medical Systems, Inc.
207.10
-0.63%
BIO Bio-Rad Laboratories, Inc.
332.10
+5.24%
PODD Insulet Corporation
235.43
-1.41%
GMED Globus Medical, Inc.
70.52
+0.24%
ZBH Zimmer Biomet Holdings, Inc.
107.71
+1.14%
TNDM Tandem Diabetes Care, Inc.
44.08
-1.25%